Cargando…
Selected Serum Markers Associated with Pathogenesis and Clinical Course of Type 1 Diabetes in Pediatric Patients—The Effect of Disease Duration
Biochemical abnormalities in the course of type 1 diabetes (T1D) may cause the production/activation of various proteins and peptides influencing treatment and causing a risk of complications. The aim of this study was to assess concentrations of selected serum substances involved in the pathogenesi...
Autores principales: | Ochocińska, Agnieszka, Wysocka-Mincewicz, Marta, Świderska, Jolanta, Cukrowska, Bożena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10051659/ https://www.ncbi.nlm.nih.gov/pubmed/36983153 http://dx.doi.org/10.3390/jcm12062151 |
Ejemplares similares
-
Could I-FABP Be an Early Marker of Celiac Disease in Children with Type 1 Diabetes? Retrospective Study from the Tertiary Reference Centre
por: Ochocińska, Agnieszka, et al.
Publicado: (2022) -
Lack of effect of Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb12 on beta-cell function in children with newly diagnosed type 1 diabetes: a randomised controlled trial
por: Groele, Lidia, et al.
Publicado: (2021) -
Peripheral Neuropathy as a Complication of Diabetic Ketoacidosis in a Child with Newly Diagnosed Diabetes Type 1: A Case Report
por: Baszyńska-Wilk, Marta, et al.
Publicado: (2018) -
Combination of HLA-DQ2/-DQ8 Haplotypes and a Single MSH5 Gene Variant in a Polish Population of Patients with Type 1 Diabetes as a First Line Screening for Celiac Disease?
por: Wysocka-Mincewicz, Marta, et al.
Publicado: (2022) -
Premature Adrenarche in Children with Prader-Willi Syndrome Treated with Recombinant Human Growth Hormone Seems to Not Influence the Course of Central Puberty and the Efficacy and Safety of the Therapy
por: Lecka-Ambroziak, Agnieszka, et al.
Publicado: (2020)